SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Volcano Corporation
(Nasdaq: VOLC), a leading developer and manufacturer of precision
guided therapy tools to enhance the diagnosis and treatment of
coronary and peripheral vascular disease, said today that it will
be participating in the 32nd Annual J.P. Morgan
Healthcare Conference on Wednesday, January
15.
The presentation by Scott
Huennekens, president and chief executive officer, will
begin at 3:30 p.m., Pacific Standard
Time (6:30 p.m., Eastern Standard
Time). The presentation will be available through
http://jpmorgan.metameetings.com/confbook/healthcare14/directlink.php?ticker=VOLC
and via the company's website at www.volcanocorp.com.
Volcano Corporation is revolutionizing the medical device
industry with a broad suite of technologies that make imaging and
therapy simpler, more informative and less invasive. Our products
empower physicians around the world with a new generation of
analytical tools that deliver more meaningful information—using
light and sound as the guiding elements. Founded in cardiovascular
care and expanding into other specialties, Volcano is changing the
assumption about what is possible in improving patient outcomes by
combining imaging and therapy together. For more information, visit
the company's website at www.volcanocorp.com.
SOURCE Volcano Corporation